Edge Wealth Management’s Editas Medicine EDIT Stock Holding History

Edge Wealth Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-25	Closed	-$1K	–	494
2020 Q2	$1K	Sell	25 -192	-88%	-$5.02K	﹤0.01%	632
2020 Q1	$4K	Sell	217 -6,608	-97%	-$167K	﹤0.01%	494
2019 Q4	$203K	Sell	6,825 -210	-3%	-$5.25K	0.04%	146
2019 Q3	$159K	Hold	7,035	–	–	0.04%	148
2019 Q2	$173K	Hold	7,035	–	–	0.04%	153
2019 Q1	$171K	Hold	7,035	–	–	0.04%	143
2018 Q4	$160K	Buy	+7,035	New	+$191K	0.05%	152

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Edge Wealth Management's EDIT Position: Q3 2020 in Review

Edge Wealth Management sold out of Editas Medicine (EDIT) in Q3 2020, closing a stake of 25 shares — an estimated $1K sold.

Edge Wealth Management first reported a position in EDIT in Q4 2018 and held it in 7 quarters. The position peaked at $203K in Q4 2019. 239 funds tracked by Wall St. Rank hold EDIT as of Q3 2020.

Edge Wealth Management reported no remaining Editas Medicine position as of Q3 2020 after selling out during the quarter.
Edge Wealth Management sold 25 Editas Medicine shares in Q3 2020, an estimated $1K.
Edge Wealth Management first reported a position in Editas Medicine in Q4 2018 and held it in 7 quarters.
Edge Wealth Management's Editas Medicine position peaked at $203K in Q4 2019.
239 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2020.

Based on Edge Wealth Management's 13F filing for Q3 2020, filed 21 Oct 2020.